v3.21.2
Consolidated Balance Sheets - USD ($)
May 31, 2021
Nov. 30, 2020
Current Assets    
Cash and cash equivalents $ 7,948,069 $ 10,361,125
Marketable securities 73,388 88,476
Accounts receivable (net of allowance for doubtful accounts of $2,794,455 and $2,781,668, respectively) 5,215,556 6,322,960
Prepaid expenses 349,936 611,627
Inventory, current portion 890,388 927,318
Other current assets 305,995 244,696
Total current assets 14,783,332 18,556,202
Property and Equipment-net 1,552,984 1,640,774
Other Assets    
Duke license agreement 15,132,189  
Intangible assets, net 1,596,849 1,181,588
Inventory, net of current portion 10,992,550 11,064,034
Goodwill 1,941,411 1,941,411
Deferred tax assets 10,363,967 10,363,967
Operating lease right-of-use asset 1,067,664 299,089
Deposits and other assets, net 579,466 495,029
Total other assets 41,982,096 26,003,118
Total assets 58,318,412 46,200,094
Current Liabilities    
Accounts payable 1,236,190 957,390
Accrued expenses 1,491,135 2,898,211
Current portion of note payable 3,100,000 3,100,000
Current portion of operating lease liability 301,613 275,570
Current portion of Duke license agreement liability 4,889,830  
Deferred revenue 9,101,008 9,183,450
Total current liabilities 20,119,776 16,414,621
Other Liabilities    
Deferred revenue, net of current portion 29,126,311 27,200,910
Contingent consideration 1,230,647 1,509,852
Note payable, net of current portion and debt issuance costs 326,286 2,841,214
Operating lease long-term liability 769,021 23,632
Long-term liability - revenue sharing agreements 875,000 875,000
Total other liabilities 34,195,518 32,450,608
Total liabilities 54,315,294 48,865,229
Commitments and contingencies (Note 9) 0 0
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 14,533,040 issued and 8,445,015 outstanding as of May 31, 2021 and 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020) 145,330 136,336
Additional paid-in capital 41,376,640 36,581,600
Treasury stock, at cost (20,563,357) (20,563,357)
Accumulated equity (16,955,495) (18,819,714)
Total stockholders' equity (deficit) 4,003,118 (2,665,135)
Total liabilities and stockholders' equity (deficit) 58,318,412 46,200,094
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment 308,000 308,000
Patent Option Agreement [Member]    
Other Assets    
Investment   $ 350,000
Duke University [Member]    
Other Liabilities    
Duke license agreement liability $ 1,868,253  

Source